SMAD3 and Alzheimer disease: Notably, enhancing Aβ clearance by peripheral macrophages through Smad3 inhibition was reported to ameliorate AD-associated Aβ deposition, neuroinflammation, and cognitive deficits, revealing novel insights into AD pathogenesis and potential therapeutic interventions.